Pharmacokinetics of Single and Multiple Escalating Doses of Aramchol Administered under Fed Conditions in Healthy Chinese Volunteers

Trial Profile

Pharmacokinetics of Single and Multiple Escalating Doses of Aramchol Administered under Fed Conditions in Healthy Chinese Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Dec 2016

At a glance

  • Drugs Aramchol (Primary)
  • Indications Non-alcoholic steatohepatitis
  • Focus Pharmacokinetics
  • Sponsors Galmed Pharmaceuticals
  • Most Recent Events

    • 20 Dec 2016 Status changed from recruiting to completed.
    • 11 Jun 2016 New trial record
    • 07 Jun 2016 The results of Part A of this study are expected to be available in August 2016, according to a Galmed Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top